Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session on Ankylosing Spondylitis: What is it?
Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, leading to pain, stiffness, and reduced mobility. Over time, AS can cause the vertebrae in the spine to fuse, resulting in a loss of flexibility and a hunched-forward posture. The disease often begins in early adulthood, and its hallmark symptom is persistent lower back pain that improves with movement but worsens with rest.
AS is considered an autoimmune disorder, with a strong genetic link, particularly with the HLA-B27 gene. In addition to affecting the spine, AS can cause inflammation in other areas such as the hips, shoulders, and even organs like the eyes (uveitis). Early diagnosis is critical to managing AS, as treatment focuses on reducing pain and inflammation, preventing or delaying spinal fusion, and maintaining posture. Treatment options include NSAIDs, physical therapy, and biologics, such as TNF inhibitors, to control inflammation and preserve mobility.
Therefore, get an overall knowledge of ankylosing spondylitis: what is it?
See More Webinars @ Hidoc Webinars
1.
A study suggests that you should disregard the "pack-years" when determining your eligibility for lung cancer screening.
2.
Why Are These Bones and Teeth Where They Shouldn't Be?
3.
Survey: Record Numbers of US Adults Report Depression.
4.
Talc Powder Not Linked to Lung Cancer in Women
5.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
1.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
2.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
3.
Unveiling the Mystery of Epstein-Barr Virus: What We Know So Far
4.
Contemporary Frameworks in Oncology Across Clinical Settings
5.
The Importance of Corrected Calcium Levels in Managing Health Conditions
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Managing Common Side Effects During Cancer Treatment
3.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
4.
How Iron Deficiency Can Affect Energy and Concentration
5.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation